The administration of hUCMSCs-Exos has been shown to have a positive impact on renal inflammation and fibrosis by decrease of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) as well as pro-fibrotic factor (TGF-β) in both kidney and bloodstream of DKD rats. This evidence concerns the gene IL6 and diabetic kidney disease.